Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023
AIDS and Behavior · 2026
DOI: 10.1007/s10461-025-04846-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2026. Verfasst von Tyler S Bartholomew und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Methamphetamine, Sexual and Gender Minorities, HIV Infections, Substance Abuse, Intravenous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAAA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Methamphetamine use is prevalent among sexual and gender minority (SGM) populations and is associated with increased risk for HIV acquisition. Studies are needed to examine the prevalence of intravenous methamphetamine use and explore its association with HIV status and PrEP uptake. Between August 2022-July 2023, 29,880 SGM people who have sex with men in the U.S. aged 16 and over completed a screening survey for a cohort study on methamphetamine use and HIV prevention. The survey captured socio-demographic characteristics, methamphetamine use (any and injection) and other substance use, and HIV-related measures (including current and previous PrEP use). The median age was 34 years and 49.7% were persons of color. Overall, 35.0% reported methamphetamine use; of whom 45.1% had injected it in the prior 12 months. Compared to people with non-injection methamphetamine use, respondents who injected methamphetamine were more likely to be older, white (vs. non-Hispanic Black or Hispanic), living with HIV or not know their status (vs. HIV-negative), to have injected cocaine, and to have had a sexual encounter without consent under the influence of alcohol/drugs. Among those who were HIV-negative, people who injected methamphetamine were less likely to currently take PrEP and more likely to have discontinued PrEP compared to those who reported non-injection methamphetamine use. Expanded efforts are needed to develop and implement targeted interventions, including PrEP and harm reduction approaches for SGM people who inject methamphetamine, to reduce risk of HIV and other infectious diseases, as well as other injection-related harms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Epidemiology, University of Florida, Gainesville, FL, USA.
- Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, NY, USA.
- CUNY Graduate School of Public Health and Health Policy, CUNY Institute for Implementation Science in Population Health, New York, NY, USA.
- Department of Medicine, Albert Einstein College of Medicine, Montefiore Health System, New York, NY, USA.
- Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, New York, NY, USA.
Förderung
- NIAID NIH HHS
- NIAAA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Bartholomew, T. S., Plesons, M., Westmoreland, D. A., D'Angelo, A. B., Mirzayi, C. A., Dearolf, M., Guo, Y., Hoeppner, E., Richards, N. S., Patel, V. V., Nash, D., Carrico, A. W., & Grov, C. (2026). Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04846-0
Vancouver
Bartholomew TS, Plesons M, Westmoreland DA, D'Angelo AB, Mirzayi CA, Dearolf M, et al. Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023. AIDS and Behavior. 2026. doi:10.1007/s10461-025-04846-0
BibTeX
@article{Bartholomew2026,
author = {Bartholomew, Tyler S and Plesons, Marina and Westmoreland, Drew A and D'Angelo, Alexa B and Mirzayi, Chloe A and Dearolf, Michelle and Guo, Yan and Hoeppner, Elena and Richards, Nicole S and Patel, Viraj V and Nash, Denis and Carrico, Adam W and Grov, Christian},
title = {Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023},
journal = {AIDS and Behavior},
year = {2026},
doi = {10.1007/s10461-025-04846-0}
}
EUVIMED